1-2 of 2
Jeffrey P. Ward
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma

Clinical Trials & Observations
Jeffrey P. Ward, Melissa M. Berrien-Elliott, Felicia Gomez, Jingqin Luo, Michelle Becker-Hapak, Amanda F. Cashen, Nina D. Wagner-Johnston, Kami Maddocks, Matthew Mosior, Mark Foster, Kilannin Krysiak, Alina Schmidt, Zachary L. Skidmore, Sweta Desai, Marcus P. Watkins, Anne Fischer, Malachi Griffith, Obi L. Griffith, Todd A. Fehniger, Nancy L. Bartlett
Journal: Blood
Blood (2022) 139 (13): 1999–2010.
https://doi.org/10.1182/blood.2021011894
Published: 2022
Includes: Supplemental data
Journal Articles

A Phase I Trial of Brentuximab Vedotin in Combination with Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Jeffrey P. Ward, MDPhD, Jessica Thein, Jingqin Luo, PhD, Nina D. Wagner-Johnston, MD, Amanda F. Cashen, MD, Todd A Fehniger, MD PhD, Nancy L Bartlett, MD
Journal: Blood
Blood (2015) 126 (23): 3988.
https://doi.org/10.1182/blood.V126.23.3988.3988
Published: 2015